Corcept Therapeutics (CORT) Current Deferred Revenue (2012 - 2015)
Corcept Therapeutics (CORT) posted Current Deferred Revenue of $158000.0 for Q4 2015, up 100.0% sequentially from $79000.0 in Q3 2015, and up 378.79% YoY from $33000.0 in Q4 2014.
Powered by 
Analysis
Corcept Therapeutics (CORT) Current Deferred Revenue (2012 - 2015) Analysis & Trends
Corcept Therapeutics has reported Current Deferred Revenue for 4 years, with the latest figure at $158000.0 in Q4 2015.
- Quarterly Current Deferred Revenue rose 378.79% year-over-year to $158000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $158000.0 (up 378.79% YoY) and the FY2015 annual result came in at $158000.0, up 378.79% from the prior year.
- Current Deferred Revenue grew to $158000.0 in Q4 2015 per CORT's latest filing, from $79000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $158000.0 in Q4 2015 and troughed at $16000.0 in Q4 2012.
- A 4-year average of $49400.0 and a median of $37000.0 in 2013 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2014 and 2015: Current Deferred Revenue slumped 61.84% in 2014, then soared 378.79% in 2015.
- Over 4 years, Current Deferred Revenue stood at $16000.0 in 2012, then jumped by 56.25% to $25000.0 in 2013, then soared by 32.0% to $33000.0 in 2014, then jumped by 378.79% to $158000.0 in 2015.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $158000.0, $79000.0, and $37000.0 for Q4 2015, Q3 2015, and Q2 2015 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Corcept Therapeutics | 11.76 Bn | 11.46 Bn | 252.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 158,000.00 |
| Sep 30, 2015 | 79,000.00 |
| Jun 30, 2015 | 37,000.00 |
| Mar 31, 2015 | 55,000.00 |
| Dec 31, 2014 | 33,000.00 |
| Sep 30, 2014 | 50,000.00 |
| Jun 30, 2014 | 44,000.00 |
| Mar 31, 2014 | 29,000.00 |
| Dec 31, 2013 | 25,000.00 |
| Sep 30, 2013 | 55,000.00 |
| Jun 30, 2013 | 37,000.00 |
| Mar 31, 2013 | 76,000.00 |
| Dec 31, 2012 | 16,000.00 |
| Sep 30, 2012 | 21,000.00 |
| Jun 30, 2012 | 26,000.00 |